KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Return on Assets (2016 - 2025)

Alnylam Pharmaceuticals' Return on Assets history spans 16 years, with the latest figure at 0.07% for Q4 2025.

  • For Q4 2025, Return on Assets rose 13.0% year-over-year to 0.07%; the TTM value through Dec 2025 reached 0.07%, up 13.0%, while the annual FY2025 figure was 0.07%, 14.0% up from the prior year.
  • Return on Assets reached 0.07% in Q4 2025 per ALNY's latest filing, up from 0.03% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.07% in Q4 2025 to a low of 0.34% in Q3 2022.
  • Average Return on Assets over 5 years is 0.17%, with a median of 0.19% recorded in 2021.
  • Peak YoY movement for Return on Assets: fell -10bps in 2022, then increased 29bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.24% in 2021, then plummeted by -33bps to 0.32% in 2022, then skyrocketed by 64bps to 0.11% in 2023, then soared by 43bps to 0.07% in 2024, then skyrocketed by 199bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Return on Assets are 0.07% (Q4 2025), 0.03% (Q3 2025), and 0.06% (Q2 2025).